Release and Expiration Dates

Click here to register for this event

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Release Date: October 1, 2011

Expiration Date: October 1, 2012

 

Fee Information

There is no fee for this educational activity.

Activity Overview

To endure the most important contents from the live FH Highlights Symposium, held in New York City in May 2011, the National Lipid Association has partnered with Elsevier to create an open-access, journal-indexed Internet CME/CE activity, based on slide highlights.

Target Audience

This Journal CME activity is designed for a broader audience of healthcare professionals including lipidologists, cardiologists, endocrinologists, internists, primary care physicians, pharmacists, nurse practitioners, physician assistants, nurses, and registered dietitians.

Learning/Educational Objectives

Upon completion of this activity, participants should be able to:

  1. Describe the prevalence and associated risk of familial hypercholesterolemia (FH) in order to increase awareness and understanding of the disease;
  2. Describe the importance of universal screening during childhood and cascade lipid screening of family members of known FH patients;
  3. Review management strategies to improve the care of patients with FH and reduce their elevated risk of CHD;
  4. Evaluate the clinical effects, safety and efficacy data for current and new treatment options for FH patients;
  5. Appraise treatment recommendations and evidence for screening, diagnosing and treating FH in both pediatric and adult patients (including women of childbearing potential and during pregnancy).

Criteria for Success

In order to receive credit, participants should review the online monograph, submit evaluation, and score at least 70% on the post-test.  Certificates will be available for download upon successful completion of the activity.  If you have questions about this CME/CE activity, please contact the NLA at cme@lipid.org.  Estimated time of completion: 60 minutes

Commercial Support Statement

This activity supported by an educational grant from Genzyme.

CME Accreditation

National_Lipid_Association.pngCME credit provided by the National Lipid Association

Physicians

The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The National Lipid Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

AKH_w120.png  CE credit provided by AKH Inc., Advancing Knowledge in Healthcare

Pharmacists

ACPE.jpg

AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  AKH Inc. approves this KNOWLEDGE - based activity for 1.0 contact hour (0.1 CEUs).  UAN 0077-9999-11-033-H04-P.
Initial release date: October 1, 2011.

Nurses

AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.
AKH Inc. designates this educational activity for 1.0 contact hour (0.1 CEU).  Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.

Dietitians

CPE.png AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.0 continuing professional education units (CPEUs) for completion of this program/material.  CDR Accredited Provider #AN008.  The focus of this activity is rated Level 2.  Learners may submit evaluations of program/materials quality to the CDR at www.cdrnet.org.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. NLA, AKH Inc., the author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader's misunderstanding of the content.

Disclosure Declaration

It is the policy of NLA and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA and AKH prior to accreditation of the activity. NLA and AKH planners and reviewers have no relevant financial relationships to disclose.

Faculty

Gidding2.jpg Samuel S. Gidding, MD
Alfred 1. duPont Hospital for Children
Nemours Cardiac Center
Wilmington, DE
Goldberg2.jpg Anne C. Goldberg, MD, FACP, FAHA, FNLA
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Ito2.jpg Matthew K. Ito, PharmD, FNLA
Professor of Pharmacy Medicine
OSU/OHSU College of Pharmacy
Portland, OR
Robinson2.jpg Jennifer G. Robinson, MD, MPH, FNLA
Professor, Departments of Epidemiology & Medicine
Director, Lipid Research Clinic
Co-Director, Prevention Intervention Center
University of Iowa
Iowa City, IA
Toth2.jpg

Peter P. Toth, MD, PhD, FAAFP, FAHA, FCCP, FACC, FNLA
Director of Preventive Cardiology, Sterling Rock Falls Clinic, Ltd.

Chief of Medicine, CGH Medical Center, Sterling, IL
Clinical Professor, University of Illinois College of Medicine
Peoria, IL

Presenting Faculty Disclosures

NAME TYPE COMMERCIAL SUPPORTERS
Samuel S. Gidding, MD Advisory Board

Merck & Co., Inc.

Anne C. Goldberg, MD Advisory Board

Genentech; Genzyme/Isis Pharmaceuticals;
Merck & Co., Inc.; Roche Pharmaceuticals

Consultant

Genentech; Genzyme/Isis Pharmaceuticals;
Merck & Co., Inc.; Roche Pharmaceuticals

Contracted Research

Abbott Laboratories, Inc.; Amarin; 
Amylin Pharmaceuticals; GlaxoSmithKline;
MannKind Corporation; Merck & Co., Inc.;
Novartis Pharmaceuticals;
Regeneron Pharmaceuticals, Inc.;
Tolerx, Inc.

Matthew K. Ito, PharmD Consultant Daiichi Sankyo, Inc.
Speakers Bureau

Abbott Laboratories, Inc.; GlaxoSmithKline;
Kowa Pharmaceuticals America, Inc.;
Merck & Co., Inc.

Jennifer G. Robinson, MD, MPH
Contracted Research

Abbott Laboratories, Inc.; Bristol-Myers Squibb;
Daiichi Sankyo, Inc.; F. Hoffmann-La Roche Ltd;
GlaxoSmithKline; Merck & Co., Inc.;
Merck/Schering-Plough Pharmaceuticals, Inc.;
Spirocor Ltd.

Peter P. Toth, MD, PhD
Consultant

Abbott Laboratories, Inc.; Amgen; Amylin
Pharmaceuticals; AstraZeneca; Kowa
Pharmaceuticals America, Inc.; Merck & Co., Inc.

Speakers Bureau

Abbott Laboratories, Inc.; AstraZeneca;
Boehringer Ingelheim; GlaxoSmithKline;
Merck & Co., Inc; Pfizer Inc.; Takeda
Pharmaceuticals North America, Inc.

Staff and Reviewers Disclosures

AKH Inc., Advancing Knowledge in Healthcare staff, planners and reviewers have no financial relationships to disclose.

National Lipid Association staff, planners and reviewers have no financial relationships to disclose.

Copyright Statement

Copyright © 2011.   The program elements and materials developed are the copyright and property of the National Lipid Association.

Policy on Privacy and Confidentiality

Dane Garvin, Ltd. (DGL) protects the privacy of personal and other information regarding participants, educational accreditation partners, and joint sponsors. DGL will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Dane Garvin, Ltd. maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.